IndraLab

Statements


2 | 1

No evidence text available

reach
"Oclacitinib inhibited JAK1, JAK2, JAK3, and TYK2 by 50% at concentrations (IC 50 's) of 10, 18, 99, and 84nm, respectively."

No evidence text available